These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 35413298)

  • 1. Molecular diagnostics of SARS-CoV-2: Findings of an international survey.
    Vacaflores Salinas A; Ashavaid T; Payne DA; Linder MW; Baluchova K; Pan S; Huggett J; Ahmad-Nejad P;
    Clin Chim Acta; 2022 Jun; 531():237-242. PubMed ID: 35413298
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Results from an IFCC global survey on laboratory practices for the analysis of circulating tumor DNA.
    Linder MW; Huggett JF; Baluchova K; Capoluongo ED; Payne DA; Salinas AV; Haselmann V; Ashavaid T; Pan S; Ahmad-Nejad P;
    Clin Chim Acta; 2023 Jul; 547():117398. PubMed ID: 37217114
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rapid, point-of-care antigen tests for diagnosis of SARS-CoV-2 infection.
    Dinnes J; Sharma P; Berhane S; van Wyk SS; Nyaaba N; Domen J; Taylor M; Cunningham J; Davenport C; Dittrich S; Emperador D; Hooft L; Leeflang MM; McInnes MD; Spijker R; Verbakel JY; Takwoingi Y; Taylor-Phillips S; Van den Bruel A; Deeks JJ;
    Cochrane Database Syst Rev; 2022 Jul; 7(7):CD013705. PubMed ID: 35866452
    [TBL] [Abstract][Full Text] [Related]  

  • 4. External quality assessment (EQA) and alternative assessment procedures (AAPs) in molecular diagnostics: findings of an international survey.
    Payne DA; Russomando G; Linder MW; Baluchova K; Ashavaid T; Steimer W; Ahmad-Nejad P;
    Clin Chem Lab Med; 2020 May; 59(2):301-306. PubMed ID: 32383687
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rapid, point-of-care antigen and molecular-based tests for diagnosis of SARS-CoV-2 infection.
    Dinnes J; Deeks JJ; Berhane S; Taylor M; Adriano A; Davenport C; Dittrich S; Emperador D; Takwoingi Y; Cunningham J; Beese S; Domen J; Dretzke J; Ferrante di Ruffano L; Harris IM; Price MJ; Taylor-Phillips S; Hooft L; Leeflang MM; McInnes MD; Spijker R; Van den Bruel A;
    Cochrane Database Syst Rev; 2021 Mar; 3(3):CD013705. PubMed ID: 33760236
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inter-laboratory testing as a strategy for external quality assessment for qualitative detection of SARS-CoV-2 by real-time RT-PCR testing in India.
    Kaur H; Mukhopadhyay L; Aggarwal N; Gupta N; Narayan J; Vijay N; Gupta S; Rana S; Kaur J; Kumar V; Singh H
    Indian J Med Res; 2022 Jan; 155(1):86-90. PubMed ID: 35859435
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rapid, point-of-care antigen and molecular-based tests for diagnosis of SARS-CoV-2 infection.
    Dinnes J; Deeks JJ; Adriano A; Berhane S; Davenport C; Dittrich S; Emperador D; Takwoingi Y; Cunningham J; Beese S; Dretzke J; Ferrante di Ruffano L; Harris IM; Price MJ; Taylor-Phillips S; Hooft L; Leeflang MM; Spijker R; Van den Bruel A;
    Cochrane Database Syst Rev; 2020 Aug; 8(8):CD013705. PubMed ID: 32845525
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Considerations for the selection of tests for SARS-CoV-2 molecular diagnostics.
    Erbak Yılmaz H; Iscan E; Oz O; Batur T; Erdoğan A; Kılıç S; Mutlu Z; Yılmaz M; Spring KJ
    Mol Biol Rep; 2022 Oct; 49(10):9725-9735. PubMed ID: 35441938
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An external quality assessment for the molecular testing of the SARS-CoV-2 virus genome in Zhejiang Province, China.
    Pan J; Yan H; Li Z; Lou X; Mao H; Shi W; Yao W; Zhang Y
    Diagn Microbiol Infect Dis; 2022 Nov; 104(3):115766. PubMed ID: 36084422
    [TBL] [Abstract][Full Text] [Related]  

  • 10. First results of a national external quality assessment scheme for the detection of SARS-CoV-2 genome sequences.
    Görzer I; Buchta C; Chiba P; Benka B; Camp JV; Holzmann H; Puchhammer-Stöckl E; Aberle SW
    J Clin Virol; 2020 Aug; 129():104537. PubMed ID: 32659712
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Understanding the Barriers to Pooled SARS-CoV-2 Testing in the United States.
    Fenichel EP; Koch RT; Gilbert A; Gonsalves G; Wyllie AL
    Microbiol Spectr; 2021 Sep; 9(1):e0031221. PubMed ID: 34378949
    [TBL] [Abstract][Full Text] [Related]  

  • 12. SARS-CoV-2: Challenges in Reconverting Diagnostic Laboratories to Combat the Pandemic.
    Barrera Saldaña HA; Rivera Santiago C; Rodríguez Palacios R
    Microbiol Spectr; 2022 Dec; 10(6):e0147722. PubMed ID: 36314981
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An Observational Laboratory-Based Assessment of SARS-CoV-2 Molecular Diagnostics in Benin, Western Africa.
    Sander AL; Yadouleton A; Moreira-Soto A; Tchibozo C; Hounkanrin G; Badou Y; Fischer C; Krause N; Akogbeto P; F de Oliveira Filho E; Dossou A; Brünink S; Drosten C; Aïssi MAJ; Harouna Djingarey M; Hounkpatin B; Nagel M; Drexler JF
    mSphere; 2021 Jan; 6(1):. PubMed ID: 33441410
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Standardization of SARS-CoV-2 Cycle Threshold Values: Multisite Investigation Evaluating Viral Quantitation across Multiple Commercial COVID-19 Detection Platforms.
    Gavina K; Franco LC; Robinson CM; Hymas W; Lei GS; Sinclair W; Hall T; Carlquist J; Lavik JP; Emery CL; Heaton PR; Hillyard D; Lopransi BK; Relich RF
    Microbiol Spectr; 2023 Feb; 11(1):e0447022. PubMed ID: 36651781
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effectiveness and cost-effectiveness of four different strategies for SARS-CoV-2 surveillance in the general population (CoV-Surv Study): a structured summary of a study protocol for a cluster-randomised, two-factorial controlled trial.
    Deckert A; Anders S; de Allegri M; Nguyen HT; Souares A; McMahon S; Boerner K; Meurer M; Herbst K; Sand M; Koeppel L; Siems T; Brugnara L; Brenner S; Burk R; Lou D; Kirrmaier D; Duan Y; Ovchinnikova S; Marx M; Kräusslich HG; Knop M; Bärnighausen T; Denkinger C
    Trials; 2021 Jan; 22(1):39. PubMed ID: 33419461
    [TBL] [Abstract][Full Text] [Related]  

  • 16. First Round of External Quality Assessment Scheme for SARS-CoV-2 Laboratories During the COVID-19 Pandemic in Thailand.
    Saeng-Aroon S; Changsom D; Boonmuang R; Waicharoen S; Buayai K; Okada P; Uppapong B; Chittaganpitch M; Soisangwan P; Praphasiri P; Skaggs BA
    Health Secur; 2023; 21(3):183-192. PubMed ID: 37196204
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nationwide External Quality Assessment of SARS-CoV-2 Molecular Testing, South Korea.
    Sung H; Han MG; Yoo CK; Lee SW; Chung YS; Park JS; Kim MN; Lee H; Hong KH; Seong MW; Lee K; Chun S; Lee WG; Kwon GC; Min WK
    Emerg Infect Dis; 2020 Oct; 26(10):2353-2360. PubMed ID: 32723432
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Analysis of external quality assessment samples revealed crucial performance differences between commercial RT-PCR assays for SARS-CoV-2 detection when taking extraction methods and real-time-PCR instruments into account.
    Malecki M; Luesebrink J; Wendel AF; Mattner F
    J Virol Methods; 2021 Sep; 295():114202. PubMed ID: 34087340
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Automated sample-to-answer centrifugal microfluidic system for rapid molecular diagnostics of SARS-CoV-2.
    Malic L; Brassard D; Da Fonte D; Nassif C; Mounier M; Ponton A; Geissler M; Shiu M; Morton KJ; Veres T
    Lab Chip; 2022 Aug; 22(17):3157-3171. PubMed ID: 35670202
    [TBL] [Abstract][Full Text] [Related]  

  • 20. RT-qPCR Diagnostics: The "Drosten" SARS-CoV-2 Assay Paradigm.
    Bustin S; Kirvell S; Huggett JF; Nolan T
    Int J Mol Sci; 2021 Aug; 22(16):. PubMed ID: 34445406
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.